GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Common Stock

Abingdon Health (LSE:ABDX) Common Stock : £0.03 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Common Stock?

Abingdon Health's quarterly common stock stayed the same from Dec. 2022 (£0.03 Mil) to Jun. 2023 (£0.03 Mil) and stayed the same from Jun. 2023 (£0.03 Mil) to Dec. 2023 (£0.03 Mil).

Abingdon Health's annual common stock increased from Jun. 2021 (£0.02 Mil) to Jun. 2022 (£0.03 Mil) but then stayed the same from Jun. 2022 (£0.03 Mil) to Jun. 2023 (£0.03 Mil).


Abingdon Health Common Stock Historical Data

The historical data trend for Abingdon Health's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Common Stock Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial 0.02 0.02 0.02 0.03 0.03

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.03

Abingdon Health Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines